Search results
17 gru 2020 · This update provides the rationale for the change in gonorrhea treatment recommendations to a higher dose (500 mg) of ceftriaxone and removal of azithromycin from the recommended regimen.
11 lip 2024 · In light of CDC’s recent changes to its gonorrhea treatment recommendations, can EPT be used for gonorrhea? Under current guidelines every effort should be made to ensure that a patient’s sex partners are evaluated and treated with the recommended regimen (a single dose of ceftriaxone 500 mg IM).
22 lip 2021 · Pages in this Section. Gonococcal Infections Among Adolescents and Adults. Gonococcal Infections Among Neonates. Gonococcal Infections Among Infants and Children. Next. Last Reviewed: July 22, 2021. Source: Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
13 kwi 2022 · The 2021 CDC STI Treatment Guidelines now recommend 500mg ceftriaxone intramuscularly once for the treatment of uncomplicated gonorrhea at all anatomic sites. If coinfection with chlamydia has not been excluded, cotreatment with doxycycline 100mg twice daily for 7 days should be added.
Previously, the CDC recommended a single 250-mg intramuscular dose of ceftriaxone and a single 1-g oral dose of azithromycin to treat uncomplicated gonorrhea as well as possible coinfection with Chlamydia trachomatis. However, review by CDC staff and other experts during 2018 and 2019 raised concerns about increasing drug resistance.
29 paź 2020 · Abstract. Gonorrhoea is a major public health concern globally. Increasing incidence and sporadic ceftriaxone-resistant cases, including treatment failures, are growing concerns. The 2020 European gonorrhoea guideline provides up-to-date evidence-based guidance regarding the diagnosis and treatment of gonorrhoea.
12 sty 2022 · Current recommendations for the treatment of gonococcal infections in adults, children, and neonates are listed in Table 5, Table 6 and Table 7, respectively. In short, the dosage of ceftriaxone has doubled since the 2015 guidelines, with further consideration of the patient’s weight.
